bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
| 105 | |
| 105 | |
| - | |
| 105 | |
| 105 | |
| 89.4227-114.2219 | |
| 12 407 M | |
| 32.1101 | |
| 118 M | |
| 3 675 M | |
| 1.3816 | |
| 0.0087 | |
| 0.179 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
OXFORD, England & MARCY-L’ETOILE, France, April 14, 2023--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based ...
Only Environmental Swabbing Assay That Simultaneously Detects Both Salmonella and Listeria Through a Single Enriched Sample with PCR Confirmation, On-Site Solution is Now Available for Implementatio...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
